JACLYN BACON: Open Payments
NPI 1265716344 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,297 in 56 payments from 23 companies in 2025. Trend: 2023 $810 · 2024 $997 · 2025 $1,297
Food & beverage: $1,297
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $200 |
| AstraZeneca Pharmaceuticals LP | 8 | $177 |
| ABBVIE INC. | 5 | $108 |
| Merck Sharp & Dohme LLC | 4 | $77 |
| Daiichi Sankyo Inc. | 3 | $77 |
| Incyte Corporation | 3 | $72 |
| Regeneron Healthcare Solutions, Inc. | 2 | $71 |
| Janssen Biotech, Inc. | 3 | $64 |
| PFIZER INC. | 2 | $57 |
| GlaxoSmithKline, LLC. | 2 | $54 |
Products named: KISQALI, KEYTRUDA, LIBTAYO, Fabhalta, IBRANCE, IMBRUVICA, LYNPARZA, Enhertu.
Industry payments across AZ — which companies pay providers there.
